Effect of replacement estrogen on insulin-like growth factor-I in postmenopausal women: The Rancho Bernardo study

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 12, 1996, Pages 4268-4271

  Goodman Gruen, Deborah ^a   Barrett Connor, Elizabeth ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; PROGESTERONE; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DRUG USE; ESTROGEN THERAPY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL;

AGED; CROSS-SECTIONAL STUDIES; ESTROGEN REPLACEMENT THERAPY; FEMALE; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MIDDLE AGED; POSTMENOPAUSE;

EID: 0029819386     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.12.4268     Document Type: Article

References (50)

1. Fryburg DA, Jahn LA, Hill SA, Oliveras DM, Barrett EJ. 1995 Insulin and insulin-like growth factor 1 enhance human skeletal muscle protein anabolism during hyperaminoacidemia by different mechanisms. J Clin Invest. 96:1722-1729.
2. Froesch ER, Burgi H, Ramseier EB, Bally P, Labhart A. 1963 Antibody-suppressible, and nonsuppressible insulin-like activities in human serum and their physiologic significance: an insulin assay with adipose tissue of increased precision and specificity. J Clin Invest. 42:1816-1834.
3. Froesch ER, Muller WA, Burgi H, Waldvogel M, Labhart A. 1966 Nonsuppressible insulin-like activity of human serum. II. Biological properties of plasma extracts with nonsuppressible insulin-like activity. Biochim Biophys Acta. 121:360-374.
4. Solomon SS, Challoner DR, Ensinck JW, Williams RH. 1967 Clearance and metabolic action of insulin and nonsuppressible insulin-like activity (NSILA) in the isolated perfused rat heart. Diabetes. 16:545-550.
5. Baylink DJ, Finkelman RD, Subburaman M. 1993 Growth factors to stimulate bone formation. J Bone Miner Res. 8[Suppl]:S565-S572.
6. Wuster C. 1995 Growth hormone, insulin-like growth factors and bone metabolism. Endocrinology and Metabolism. 2:3-12.
7. LeRoith D, Baserga R, Helman L, Roberts C. 1995 Insulin-like growth factors, and cancer. Ann Intern Med. 122:54-59.
8. Bach LA, Rechler MM. 1992 Insulin-like growth factors, and diabetes. Diabetes Metab Rev. 8:229-257.
9. Lee W-H, Bondy C. 1993 Insulin-like growth factors, and cerebral ischemia. Ann NY Acad Sci. 679:418-422.
10. Ljunghall S, Johansson AB, Burman P, Kampe O, Lindh E, Karlsson FA. 1992 Low plasma levels of insulin-like growth factor I (IGF-I) in male patients with idiopathic osteoporosis. J Intern Med. 232:59-64.
11. Rudman D, Feller AG, Hagraj HS, Gernans GA, Lalitha PY, Goldberg AF, et al. 1990 Effect of human growth hormone in men over 60 years old. N Engl J Med. 323:1-6.
12. Johansson AG, Burman P, Westermark K, Ljunghall S. 1992 The bone mineral density in acquired growth hormone deficiency correlates with circulating levels of insulin-like growth factor I. J Intern Med. 232:447-452.
13. Hirschberg R, Kopple JD. 1995 Insulin-like growth factor I, and renal function. Diabetes Rev. 3:177-195.
14. Froesch ER, Zapf J. 1985 Insulin-like growth factor, and insulin: comparative aspects. Diabetologia. 28:485-493.
15. Ho KY, Evans WS, Blizzard RM, et al. 1987 Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab. 64:51-58.
16. Bennett AE, Wahner HW, Riggs BL, Hintz RL. 1984 Insulin-like growth factors I, and II: aging and bone density in women. J Clin Endocrinol Metab. 59:701-704.
17. Franchimont P, Urbain-Choffray D, Lambelin P, Fontaine M-A, Frangin G, Reginster J-Y. 1989 Effect of repetitive administration of growth hormone-releasing hormone on growth hormone secretion, insulin-like growth factor I, and bone metabolism in postmenopausal women. Acta Endocrinol (Copenh). 120:121-128.
18. Raven P, Overgaard K, Spencer EM, Christiansen C. 1995 Insulin-like growth factors I, and II in healthy women with and without established osteoporosis. Eur J Endocrinol. 132:313-319.
19. Dawson-Hughes B, Stern D, Goldman J, Reichlin S. 1986 Regulation of growth hormone and somatomedin-C secretion in postmenopausal women: effect of physiological estrogen replacement. J Clin Endocrinol Metab. 63:424-432.
20. Duursma SA, Bijlsma WJ, Paassen HC, van Buul-Offers SC, Skottner-Lundin A. 1984 Changes in serum somatomedin and growth hormone concentrations after 3 weeks oestrogen substitution in post-menopausal women; a pilot study. Acta Endocrinol (Copenh). 6:527-531.
21. Weissberger AJ, Ho KKY, Lazarus L. 1991 Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor I, and GH-binding protein in postmenopausal women. J Clin Endocrinol Metab. 72:374-381.
22. Campagnoli C, Biglia N, Altare F, et al. 1993 Differential effects of oral conjugated estrogens and transdermal estradiol on insulin-like growth factor 1, growth hormone and sex hormone binding globulin serum levels. Gynecol Endocrinol. 7:251-258.
23. Landin-Wilhelmsen K, Wilhelmsen L, Lappas G, et al. 1994 Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clinical Endocrinology. 41:351-357.
24. Wingard DL, Sinsheimer P, Barrett-Connor E, et al. 1990 Community-based study of prevalence of NIDDM in older adults. Diabetes Care. 13:3-8.
25. Daughaday WH, Mariz IK, Blethen SI. 1980 Inhibition of access of bound somatomedin to membrane receptor and immunobinding sites: a comparison of radioreceptor and radioimmunoassay of somatomedin in native and acid-ethanol extracted serum. J Clin Endocrinol Metab. 51:781-788.
26. Cohick S, Clemmons DR. 1993 The insulin-like growth factors. Annu Rev Physiol. 55:131-153.
27. Slowinska-Srzednicka J, Zgliczynski S, Jeske W, et al. 1992 17β-estradiol combined with oral progestogen increases plasma levels of insulin-like growth factor-I in postmenopausal women. J Endocrinol Invest. 15:533-538.
28. Bellantoni MF, Harman SM, Cho DE, Blackman MR. 1991 Effects of progestin-opposed transdermal estrogen administration on growth hormone and insulin-like growth factor-I in postmenopausal women of different ages. J Clin Endocrinol Metab. 72:172-178.
29. Campagnoli C, Biglia N, Lanza MG, Lesca L, Peris C, Sismondi P. 1994 Androgenic progestogens oppose the decrease of insulin-like growth factor I serum level induced by conjugated oestrogens in postmenopausal women. Preliminary report. Maturitas. 19:25-31.
30. Chetkowski RJ, Meldrum DR, Steingold KA, et al. 1986 Biological effects of transdermal estradiol. N Engl J Med. 314:1615-1620.
31. de Lignieres B, Basdevant A, Thomas G, et al. 1986 Biological effects of estradiol-17b in postmenopausal women: oral versus percutaneous administration. J Clin Endocrinol Metab. 62:536-541.
32. Selby PI, McGarrigle HHG, Peacock M. 1989 Comparison of the effects of oral and transdermal oestradiol administration on oestrogen metabolism, protein synthesis, gonadotropin release, bone turnover and climacteric symptoms in postmenopausal women. Clin Endocrinol (Oxf). 30:241-249.
33. Murphy LJ, Friesen HG. 1988 Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor I gene expression in the ovariectomized hypophysectomized rat. Endocrinology. 122:325-332.
34. Manolio TA, Furberg CD, Shemanski L, et al. 1993 Associations of post-menopausal estrogen use with cardiovascular disease and its risk factors in older women. Circulation. 88:2163-2171.
35. Nabulsi AA, Folsom AR, White A, et al. 1993 Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk In Communities Study Investigators. N Engl J Med. 328:1069-1075.
36. Boulware SD, Tamborlane WV, Sherwin RS. 1995 Effects of IGF-I on carbohydrate and lipid metabolism. Diabetes Rev. 3:196-205.
37. Nachtigal LE, Nachtigall RH, Bachtigall RD, Beckman EM. 1979 Estrogen replacement therapy I: a 10 year prospective study in the relationship to osteoporosis. Obstet Gynecol. 53:277-281.
38. Laron Z, Klinger B. 1993 Body fat in Laron syndrome patients: effect of insulin-like growth factor I treatment. Horm Res. 40:16-22.
39. The Writing Group for the PEPI Trial. 1995 Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. JAMA. 273:199-208.
40. Barrett-Connor E, Wingard DL, Criqui MH. 1989 Postmenopausal estrogen use and heart disease risk factors in the 1980s. JAMA. 261:2095-2100.
41. Kelly JJ, Rajkovic IA, O'Sullivan AJ, Sernia C, Ho KK. 1993 Effects of different oral oestrogen formulations on insulin-like growth factor-I, growth hormone and growth hormone binding protein in post-menopausal women. Clin Endocrinol (Oxf). 39:561-567.
42. Murphy LJ, Friesen HG. 1988 Differential effects of estrogen and growth hormone on uterine and hepatic insulin-like growth factor I gene expression in the ovariectomized hypophysectomized rat. Endocrinology. 122:325-332.
43. Salomon F, Cuneo RC, Hesp R, Sonksen PH. 1989 The effects of treatment with recombinant human growth hormone on body composition and metabolism and adults with growth hormone deficiency. N Engl J Med. 312:1797-1803.
44. Marcus R, Butterfield G, Holloway L, et al. 1990 Effects of short-term administration of rhGH to elderly people. J Clin Endocrinol Metab. 7:519-527.
45. Schlemmer A, Johansen JS, Pedersen SA, Jorgensen J, Hassager C. 1991 The effect of growth hormone (GH) therapy on urinary pyridinoline cross links in GH-deficient adults. Clin Endocrinol (Oxf). 35:471-476.
46. Brixen K, Nielsen HK, Moskilde L, Flyvbjerg A. 1990 A short course of rhGH treatment stimulates osteoblasts and activates bone remodeling in normal human volunteers. J Bone Miner Res. 5:609-618.
47. Cuneo RC, Salomon F, Watts GF, Hesp R, Sonksen PH. 1993 Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency. Metabolism. 42:1519-1523.
48. Eden S, Wiklund O, Oscarsson J, Rosen T, Bengtsson B-A. 1993 Growth hormone treatment of growth hormone deficient adults results in marked increase in Lp(a) and HDL cholesterol concentrations. Arterioscler Thromb. 13:296-301.
49. Corpas E, Harman SM, Blackman MR. 1993 Human growth hormone and human aging. Endocr Rev. 14:20-39.
50. Daniels GH, Martin JB. 1991 Neuroendocrine regulation and diseases of the anterior pituitary and hypothalamus. In: Wilson JD, Brauwald E, Isselbacker, KJ, et al. (eds) Harrison's Principles of Internal Medicine, ed 12. New York: McGraw-Hill; vol 2:1655-1679.